2024
The ability of contemporary cardiologists to judge the ischemic impact of a coronary lesion visually.
Foley M, Rajkumar CA, Ahmed-Jushuf F, Nour D, Fung CH, Seligman H, Pathimagaraj RH, Petraco R, Sen S, Nijjer S, Howard JP, Ahmad Y, Allahwala U, Bhindi R, Chamie D, Doi S, Kuwata S, Kaihara T, Koga M, Ishibashi Y, Higuma T, Tanabe Y, Nakayama M, Kawase Y, Watanabe A, Funayama N, Horinaka R, Hijikata N, Takahashi T, Matsuo H, Hansen PS, Manica A, Weaver J, Alzuhairi K, Yong TH, Warisawa T, Francis DP, Shun-Shin MJ, Al-Lamee RK. The ability of contemporary cardiologists to judge the ischemic impact of a coronary lesion visually. Cardiovasc Revasc Med 2024, 59: 60-66. PMID: 37612169, DOI: 10.1016/j.carrev.2023.08.003.Peer-Reviewed Original ResearchIntravascular Imaging–Guided Versus Angiography‐Guided Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis of Randomized Trials
Sreenivasan J, Reddy R, Jamil Y, Malik A, Chamie D, Howard J, Nanna M, Mintz G, Maehara A, Ali Z, Moses J, Chen S, Chieffo A, Colombo A, Leon M, Lansky A, Ahmad Y. Intravascular Imaging–Guided Versus Angiography‐Guided Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis of Randomized Trials. Journal Of The American Heart Association 2024, 13: e031111. PMID: 38214263, PMCID: PMC10926835, DOI: 10.1161/jaha.123.031111.Peer-Reviewed Original ResearchConceptsAdverse cardiac eventsPercutaneous coronary interventionAngiography-guided percutaneous coronary interventionTarget vessel revascularizationTarget-lesion revascularizationCardiac eventsCardiac deathImaging-guided percutaneous coronary interventionWeighted mean follow-up durationMeta-analysisPrimary outcomeMean follow-up durationStent thrombosisMeta-analysis of randomized trialsStudy-level meta-analysisComplex lesion subsetsIntravascular imagingAll-cause deathRandom-effects meta-analysisStandard of careIntention-to-treat principleUpdates of clinical guidelinesMixed-effects meta-regressionComplex percutaneous coronary interventionIntravascular imaging-guided percutaneous coronary intervention
2023
Rationale and design of the INVICTUS Registry: (Multicenter Registry of Invasive and Non-Invasive imaging modalities to compare Coronary Computed Tomography Angiography, Intravascular Ultrasound and Optical Coherence Tomography for the determination of Severity, Volume and Type of coronary atherosclerosiS).
Nakanishi R, Okubo R, Sobue Y, Kaneko U, Sato H, Fujimoto S, Nozaki Y, Kajiya T, Miyoshi T, Ichikawa K, Abe M, Kitagawa T, Ikenaga H, Osawa K, Saji M, Iguchi N, Nakazawa G, Takahashi K, Ijich T, Mikamo H, Kurata A, Moroi M, Iijima R, Malkasian S, Crabtree T, Chamie D, Alexandra LJ, Min JK, Earls JP, Matsuo H. Rationale and design of the INVICTUS Registry: (Multicenter Registry of Invasive and Non-Invasive imaging modalities to compare Coronary Computed Tomography Angiography, Intravascular Ultrasound and Optical Coherence Tomography for the determination of Severity, Volume and Type of coronary atherosclerosiS). J Cardiovasc Comput Tomogr 2023, 17: 401-406. PMID: 37679247, DOI: 10.1016/j.jcct.2023.08.011.Peer-Reviewed Original ResearchA randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trial.
Kanagaratnam P, Francis DP, Chamie D, Coyle C, Marynina A, Katritsis G, Paiva P, Szigeti M, Cole G, de Andrade Nunes D, Howard J, Esper R, Khan M, More R, Barreto G, Meneguz-Moreno R, Arnold A, Nowbar A, Kaura A, Mariveles M, March K, Shah J, Nijjer S, Lip GYH, Mills N, Camm AJ, Cooke GS, Corbett SJ, Llewelyn MJ, Ghanima W, Toshner M, Peters N, Petraco R, Al-Lamee R, Boshoff ASM, Durkina M, Malik I, Ruparelia N, Cornelius V, Shun-Shin M. A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trial. J Thromb Haemost 2023, 21: 2213-2222. PMID: 37230416, DOI: 10.1016/j.jtha.2023.04.045.Peer-Reviewed Original ResearchIoxaglate Versus IoDixanol for the Prevention of Contrast-Induced Nephropathy: The IDPC Trial.
Freitas RAP, Tanajura LF, Mehran R, Chamié D, Chaves A, Centemero M, Braga S, Costa R, Cao D, Sousa A, Feres F, Costa JR Jr. Ioxaglate Versus IoDixanol for the Prevention of Contrast-Induced Nephropathy: The IDPC Trial. J Invasive Cardiol 2023, 35: E281-E290. PMID: 37220640.Peer-Reviewed Original ResearchSerial Assessment of Coronary Artery Healing of a Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months by Optical Coherence Tomography (OCT)-The REPAIR Trial.
Silva GBG, Meneguz-Moreno RA, Costa R, Chamié D, Dangas G, Manica A, Arruda JA, Sousa AGMR, Feres F, Costa JR Jr. Serial Assessment of Coronary Artery Healing of a Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months by Optical Coherence Tomography (OCT)-The REPAIR Trial. J Invasive Cardiol 2023, 35: E225-E233. PMID: 36920890.Peer-Reviewed Original ResearchIntravascular Imaging Use by Intermediate to High-Volume US Operators – A Medicare Data Analysis
See C, Sawano M, Nagpal S, Chamie D, Curtis J, Murugiah K. Intravascular Imaging Use by Intermediate to High-Volume US Operators – A Medicare Data Analysis. Journal Of The Society For Cardiovascular Angiography & Interventions 2023, 2: 100977. PMID: 37854494, PMCID: PMC10584013, DOI: 10.1016/j.jscai.2023.100977.Peer-Reviewed Original ResearchSinus of Valsalva Pseudoaneurysm: An Unusual Cause of Complete Heart Block.
Centemero M, Urdanetta LR, Maschiarelli I, Barreto R, Mendez CA, Delamain JH, Wolf PW, Terrível D, Feres F, Chamié D. Sinus of Valsalva Pseudoaneurysm: An Unusual Cause of Complete Heart Block. JACC Case Rep 2023, 14: 101832. PMID: 37077873, DOI: 10.1016/j.jaccas.2023.101832.Peer-Reviewed Case Reports and Technical NotesNon-hyperemic pressure ratios – theoretical basis, clinical applications, and limitations
Daniel Chamié Júlio Maia Tales Raminho Lara Eurípedes Lucas Sant'Anna Adriano Caixeta Fernando Sant'Anna Journal of Transcatheter Interventions vol. 31 (2023) pp: 1-16Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2022
Intravascular Imaging for Percutaneous Coronary Intervention Guidance and Optimization: The Evidence for Improved Patient Outcomes
Gary S. Mintz, Christos V. Bourantas, Daniel Chamié, Intravascular Imaging for Percutaneous Coronary Intervention Guidance and Optimization: The Evidence for Improved Patient Outcomes, Journal of the Society for Cardiovascular Angiography & Interventions, Volume 1, Issue 6, 2022, 100413, ISSN 2772-9303, https://doi.org/10.1016/j.jscai.2022.100413. (https://www.sciencedirect.com/science/article/pii/S2772930322004045)Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsFractional flow reserve: physiological bases, clinical applications and limitations
Sant’Anna FM, Bandeira DG, Sant’Anna LB, Casagrande B, Maia JD, Caixeta A, Zukowski CN, Chamié D. Fractional flow reserve: physiological bases, clinical applications and limitations. J Transcat Intervent. 2022 Jan 27;30.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2021
Healing and early stent coverage after ultrathin strut biodegradable polymer-coated sirolimus-eluting stent implantation: SiBi optical coherence tomography study.
Abhyankar A, Abizaid A, Chamié D, Patel G. Healing and early stent coverage after ultrathin strut biodegradable polymer-coated sirolimus-eluting stent implantation: SiBi optical coherence tomography study. Catheter Cardiovasc Interv 2021, 98: 1335-1342. PMID: 33247618, DOI: 10.1002/ccd.29371.Peer-Reviewed Original ResearchResponse by Chamié et al to Letter Regarding Article, "Optical Coherence Tomography Versus Intravascular Ultrasound and Angiography to Guide Percutaneous Coronary Interventions: The iSIGHT Randomized Trial".
Chamié D, Petraco R, Feres F. Response by Chamié et al to Letter Regarding Article, "Optical Coherence Tomography Versus Intravascular Ultrasound and Angiography to Guide Percutaneous Coronary Interventions: The iSIGHT Randomized Trial". Circ Cardiovasc Interv 2021, 14: e011004. PMID: 34182787, DOI: 10.1161/CIRCINTERVENTIONS.121.011004.Commentaries, Editorials and LettersStent type identification with optical coherence tomography: novelty in search of clinical application.
Chamié D, Petraco R. Stent type identification with optical coherence tomography: novelty in search of clinical application. EuroIntervention 2021, 17: e103-e104. PMID: 34110287, DOI: 10.4244/EIJV17I2A19.Commentaries, Editorials and LettersOptical Coherence Tomography Versus Intravascular Ultrasound and Angiography to Guide Percutaneous Coronary Interventions: The iSIGHT Randomized Trial.
Chamié D, Costa JR Jr, Damiani LP, Siqueira D, Braga S, Costa R, Seligman H, Brito F, Barreto G, Staico R, Feres F, Petraco R, Abizaid A. Optical Coherence Tomography Versus Intravascular Ultrasound and Angiography to Guide Percutaneous Coronary Interventions: The iSIGHT Randomized Trial. Circ Cardiovasc Interv 2021, 14: e009452. PMID: 33685212, DOI: 10.1161/CIRCINTERVENTIONS.120.009452.Peer-Reviewed Original ResearchComparison of neointimal coverage between ultrathin biodegradable polymer-coated sirolimus-eluting stents and durable polymer-coated everolimus-eluting stents: 6 months optical coherence tomography follow-up from the TAXCO study.
Abhyankar A, Abizaid A, Chamié D, Rathod M. Comparison of neointimal coverage between ultrathin biodegradable polymer-coated sirolimus-eluting stents and durable polymer-coated everolimus-eluting stents: 6 months optical coherence tomography follow-up from the TAXCO study. Catheter Cardiovasc Interv 2021, 97: 423-430. PMID: 32243050, DOI: 10.1002/ccd.28833.Peer-Reviewed Original ResearchComparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trial.
Prado GFA Jr, Abizaid AAC, Meireles GC, Sarmento-Leite R, Prudente M, Cantarelli M, Dourado AD, Jr JM, Perin MA, Costantini C, Costa R, Costa JR, Chamie D, Campos CM, Ribeiro EE, Lemos PA. Comparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trial. Rev Port Cardiol (Engl Ed) 2021, 40: 71-76. PMID: 33402278, DOI: 10.1016/j.repc.2020.05.017.Peer-Reviewed Original Research
2020
Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system.
Verheye S, Vrolix M, Montorfano M, Zivelonghi C, Giannini F, Bedogni F, Dubois C, De Bruyne B, Costa RA, Chamié D, de Ribamar Costa J Jr, Kereiakes DJ, Abizaid AA, Colombo A. Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system. EuroIntervention 2020, 16: e974-e981. PMID: 32894231, DOI: 10.4244/EIJ-D-20-00763.Peer-Reviewed Original ResearchAdapted Catheterization Laboratory Practices during the COVID-19 Pandemic: The Instituto Dante Pazzanese de Cardiologia Protocol.
Chamié D, Oliveira F, Braga S, Costa JR, Siqueira DAA, Staico R, Costa R, Maldonado G, Tanajura LFL, Centemero MP, Chaves ÁJ, Abizaid ACSL, Freitas RAP, Coelho NT, Ohe LN, Abboud C, Feres F. Adapted Catheterization Laboratory Practices during the COVID-19 Pandemic: The Instituto Dante Pazzanese de Cardiologia Protocol. Arq Bras Cardiol 2020, 115: 558-568. PMID: 33027381, DOI: 10.36660/abc.20200489.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsDiagnostic Accuracy of 320-Row Computed Tomography for Characterizing Coronary Atherosclerotic Plaques: Comparison with Intravascular Optical Coherence Tomography.
Ybarra LF, Szarf G, Ishikawa W, Chamié D, Caixeta A, Puri R, Perin MA. Diagnostic Accuracy of 320-Row Computed Tomography for Characterizing Coronary Atherosclerotic Plaques: Comparison with Intravascular Optical Coherence Tomography. Cardiovasc Revasc Med 2020, 21: 640-646. PMID: 31501019, DOI: 10.1016/j.carrev.2019.08.010.Peer-Reviewed Original Research